Tranexamic Acid Suppliers & Bulk Manufacturers
Available Forms: Oral & Injectable
Available Strengths: Oral Tablets: 250 mg, 500 mg, 650 mg & (IV) Injection::100 mg/mL
Reference Brands: Lysteda, Cyklokapron®, Transamin®,
Category:
Anemia
Tranexamic Acid is an antifibrinolytic agent used to prevent and treat excessive bleeding, available in oral and injectable forms for B2B pharma distribution in the US and EU.
Tranexamic Acid is available in Oral & Injectable
and strengths such as Oral Tablets: 250 mg, 500 mg, 650 mg & (IV) Injection::100 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tranexamic Acid is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tranexamic Acid can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tranexamic Acid is a widely used antifibrinolytic agent available for B2B pharmaceutical supply across the US and EU. Indicated for the treatment and prevention of excessive bleeding, including heavy menstrual bleeding, surgical hemorrhage, and trauma-related blood loss, Tranexamic Acid helps stabilize clots by inhibiting plasminogen activation. Offered in both oral (500 mg tablets) and injectable (100 mg/mL) forms, it is ideal for hospitals, clinics, and gynecology practices. Regulatory-compliant and GMP-certified, Tranexamic Acid ensures high demand across markets focused on bleeding control and pre-operative care. B2B partners benefit from reliable sourcing and strong market demand in both acute and chronic care settings.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing